Price to Earnings (P/E)
since 2005
Calculation
Celgene Corp., P/E, long-term trends, calculation
| P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Net income (loss) attributable to Celgene1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2019 | 15.57 | = | 89.71 | ÷ | 5.76 | 5.76 | = | 4,046 | ÷ | 702,164,345 | |
| Feb 7, 2018 | 24.35 | = | 95.16 | ÷ | 3.91 | 3.91 | = | 2,940 | ÷ | 752,175,608 | |
| Feb 10, 2017 | 44.99 | = | 115.61 | ÷ | 2.57 | 2.57 | = | 1,999 | ÷ | 777,966,471 | |
| Feb 11, 2016 | 48.59 | = | 99.59 | ÷ | 2.05 | 2.05 | = | 1,602 | ÷ | 781,664,535 | |
| Feb 20, 2015 | 49.41 | = | 123.43 | ÷ | 2.50 | 2.50 | = | 2,000 | ÷ | 800,590,656 | |
| Feb 13, 2014 | 46.13 | = | 82.37 | ÷ | 1.79 | 1.79 | = | 1,450 | ÷ | 812,040,158 | |
| Feb 15, 2013 | 28.41 | = | 49.39 | ÷ | 1.74 | 1.74 | = | 1,456 | ÷ | 837,488,894 | |
| Feb 22, 2012 | 24.85 | = | 37.32 | ÷ | 1.50 | 1.50 | = | 1,318 | ÷ | 877,620,608 | |
| Mar 1, 2011 | 27.99 | = | 26.51 | ÷ | 0.95 | 0.95 | = | 881 | ÷ | 929,797,930 | |
| Feb 18, 2010 | 35.45 | = | 29.95 | ÷ | 0.84 | 0.84 | = | 777 | ÷ | 919,461,836 | |
| Feb 17, 2009 | — | = | 25.94 | ÷ | -1.67 | -1.67 | = | -1,534 | ÷ | 918,926,334 | |
| Feb 20, 2008 | 97.86 | = | 27.44 | ÷ | 0.28 | 0.28 | = | 226 | ÷ | 807,518,156 | |
| Feb 27, 2007 | 291.07 | = | 26.59 | ÷ | 0.09 | 0.09 | = | 69 | ÷ | 755,105,544 | |
| Mar 15, 2006 | 222.19 | = | 20.50 | ÷ | 0.09 | 0.09 | = | 64 | ÷ | 689,939,580 |
Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Celgene Corp. Annual Report.
Comparison to Competitors
Celgene Corp., P/E, long-term trends, comparison to competitors
| Celgene Corp. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2019 | 15.57 | 20.60 | 14.01 | 16.81 | 29.77 | 39.13 | 15.26 | 23.74 | 33.46 | — | 21.58 | 18.17 | 35.19 |
| Feb 7, 2018 | 24.35 | 35.47 | 64.06 | 103.55 | 27.25 | — | 22.75 | 268.10 | 61.63 | — | 9.99 | 28.99 | 37.66 |
| Feb 10, 2017 | 44.99 | 16.54 | 16.03 | 20.56 | 23.02 | 32.39 | 6.83 | 20.08 | 46.14 | — | 28.10 | 42.64 | 30.45 |
| Feb 11, 2016 | 48.59 | 17.01 | 15.95 | 64.22 | 17.85 | 33.35 | 6.75 | 18.80 | 31.64 | — | 26.37 | 60.50 | 26.19 |
| Feb 20, 2015 | 49.41 | 55.08 | 22.96 | 49.80 | 23.69 | 33.06 | 12.85 | 17.15 | 13.94 | — | 23.03 | 118.44 | 27.26 |
| Feb 13, 2014 | 46.13 | 19.64 | 18.69 | 35.01 | 19.74 | 13.88 | 42.00 | 18.72 | 37.83 | — | 9.32 | 77.00 | 38.43 |
| Feb 15, 2013 | 28.41 | 11.51 | 15.68 | 30.56 | 17.73 | 14.99 | 25.20 | 19.64 | 20.94 | — | 13.51 | 21.42 | 22.54 |
| Feb 22, 2012 | 24.85 | — | 14.61 | 15.07 | 16.92 | 10.42 | 12.20 | 18.48 | 18.63 | — | 15.99 | — | 15.58 |
| Mar 1, 2011 | 27.99 | — | 10.53 | 13.99 | 18.29 | 7.86 | 10.68 | 12.23 | 116.63 | — | 18.63 | — | 20.87 |
| Feb 18, 2010 | 35.45 | — | 12.10 | 4.03 | 20.93 | 9.18 | 16.29 | 14.22 | 9.00 | — | 16.41 | — | 23.49 |
| Feb 17, 2009 | — | — | 12.06 | 7.68 | 12.56 | — | 20.29 | 11.67 | 6.53 | — | 10.25 | — | 15.25 |
| Feb 20, 2008 | 97.86 | — | 15.64 | 20.60 | 17.35 | 19.26 | 25.19 | 17.07 | 29.88 | — | 18.51 | — | 30.76 |
| Feb 27, 2007 | 291.07 | — | 25.43 | 34.64 | 19.65 | 22.40 | — | 17.02 | 21.57 | — | 9.18 | — | 113.28 |
| Mar 15, 2006 | 222.19 | — | 23.70 | 14.96 | 21.38 | 31.90 | 34.15 | 16.95 | 16.62 | — | 23.92 | — | 25.36 |
Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Celgene Corp., P/E, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Celgene Corp. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Feb 26, 2019 | 15.57 | 23.13 |
| Feb 7, 2018 | 24.35 | 34.49 |
| Feb 10, 2017 | 44.99 | 20.28 |
| Feb 11, 2016 | 48.59 | 18.89 |
| Feb 20, 2015 | 49.41 | 20.74 |
| Feb 13, 2014 | 46.13 | 19.10 |
| Feb 15, 2013 | 28.41 | 17.34 |
| Feb 22, 2012 | 24.85 | 16.25 |
| Mar 1, 2011 | 27.99 | 15.61 |
| Feb 18, 2010 | 35.45 | 11.39 |
| Feb 17, 2009 | — | 11.95 |
| Feb 20, 2008 | 97.86 | 19.74 |
| Feb 27, 2007 | 291.07 | 17.28 |
| Mar 15, 2006 | 222.19 | 20.69 |
Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Celgene Corp., P/E, long-term trends, comparison to industry (health care)
| Celgene Corp. | Health Care | |
|---|---|---|
| Feb 26, 2019 | 15.57 | 25.51 |
| Feb 7, 2018 | 24.35 | 29.68 |
| Feb 10, 2017 | 44.99 | 21.38 |
| Feb 11, 2016 | 48.59 | 19.10 |
| Feb 20, 2015 | 49.41 | 20.89 |
| Feb 13, 2014 | 46.13 | 18.14 |
| Feb 15, 2013 | 28.41 | 15.43 |
| Feb 22, 2012 | 24.85 | 15.48 |
| Mar 1, 2011 | 27.99 | 14.45 |
| Feb 18, 2010 | 35.45 | 11.43 |
| Feb 17, 2009 | — | 12.78 |
| Feb 20, 2008 | 97.86 | 18.99 |
| Feb 27, 2007 | 291.07 | 18.38 |
| Mar 15, 2006 | 222.19 | 21.11 |
Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).